Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12410048rdf:typepubmed:Citationlld:pubmed
pubmed-article:12410048lifeskim:mentionsumls-concept:C0010031lld:lifeskim
pubmed-article:12410048lifeskim:mentionsumls-concept:C0023194lld:lifeskim
pubmed-article:12410048lifeskim:mentionsumls-concept:C0677043lld:lifeskim
pubmed-article:12410048lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:12410048lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:12410048lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:12410048pubmed:issue8lld:pubmed
pubmed-article:12410048pubmed:dateCreated2002-10-31lld:pubmed
pubmed-article:12410048pubmed:abstractTextLecithin-cholesterol acyltransferase (LCAT) deficiency is a rare entity. This dyslipoproteinemia may lead to corneal opacity, renal failure, and arteriosclerosis.lld:pubmed
pubmed-article:12410048pubmed:languageenglld:pubmed
pubmed-article:12410048pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12410048pubmed:citationSubsetIMlld:pubmed
pubmed-article:12410048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12410048pubmed:statusMEDLINElld:pubmed
pubmed-article:12410048pubmed:monthNovlld:pubmed
pubmed-article:12410048pubmed:issn0277-3740lld:pubmed
pubmed-article:12410048pubmed:authorpubmed-author:Schlötzer-Sch...lld:pubmed
pubmed-article:12410048pubmed:authorpubmed-author:SeitzBerthold...lld:pubmed
pubmed-article:12410048pubmed:authorpubmed-author:KüchleMichael...lld:pubmed
pubmed-article:12410048pubmed:authorpubmed-author:ViestenzArneAlld:pubmed
pubmed-article:12410048pubmed:authorpubmed-author:Hofmann-Rumme...lld:pubmed
pubmed-article:12410048pubmed:issnTypePrintlld:pubmed
pubmed-article:12410048pubmed:volume21lld:pubmed
pubmed-article:12410048pubmed:ownerNLMlld:pubmed
pubmed-article:12410048pubmed:authorsCompleteYlld:pubmed
pubmed-article:12410048pubmed:pagination834-7lld:pubmed
pubmed-article:12410048pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:12410048pubmed:meshHeadingpubmed-meshheading:12410048...lld:pubmed
pubmed-article:12410048pubmed:meshHeadingpubmed-meshheading:12410048...lld:pubmed
pubmed-article:12410048pubmed:meshHeadingpubmed-meshheading:12410048...lld:pubmed
pubmed-article:12410048pubmed:meshHeadingpubmed-meshheading:12410048...lld:pubmed
pubmed-article:12410048pubmed:meshHeadingpubmed-meshheading:12410048...lld:pubmed
pubmed-article:12410048pubmed:meshHeadingpubmed-meshheading:12410048...lld:pubmed
pubmed-article:12410048pubmed:meshHeadingpubmed-meshheading:12410048...lld:pubmed
pubmed-article:12410048pubmed:meshHeadingpubmed-meshheading:12410048...lld:pubmed
pubmed-article:12410048pubmed:meshHeadingpubmed-meshheading:12410048...lld:pubmed
pubmed-article:12410048pubmed:year2002lld:pubmed
pubmed-article:12410048pubmed:articleTitleHistopathology of corneal changes in lecithin-cholesterol acyltransferase deficiency.lld:pubmed
pubmed-article:12410048pubmed:affiliationDepartment of Ophthalmology, University Eye Hospital, University of Erlangen-Nürnberg, Erlangen, Germany. Arne.Viestenz@t-online.delld:pubmed
pubmed-article:12410048pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12410048pubmed:publicationTypeCase Reportslld:pubmed